These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 8620490)

  • 1. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
    Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines.
    Brady G; Crean SJ; Naik P; Kapas S
    Int J Oncol; 2007 Oct; 31(4):875-81. PubMed ID: 17786320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1.
    Hembree JR; Agarwal C; Eckert RL
    Cancer Res; 1994 Jun; 54(12):3160-6. PubMed ID: 7515765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not.
    Okazaki R; Conover CA; Harris SA; Spelsberg TC; Riggs BL
    J Bone Miner Res; 1995 May; 10(5):788-95. PubMed ID: 7639114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
    Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
    J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
    Reynolds RK; Hu C; Baker VV
    Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells.
    Steller MA; Delgado CH; Zou Z
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11970-4. PubMed ID: 8618825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.
    Bergmann U; Funatomi H; Yokoyama M; Beger HG; Korc M
    Cancer Res; 1995 May; 55(10):2007-11. PubMed ID: 7743492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
    Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
    Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
    Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
    Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
    Sun HZ; Wu SF; Tu ZH
    Cell Res; 2001 Jun; 11(2):107-15. PubMed ID: 11453542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells.
    Chen SC; Chou CK; Wong FH; Chang CM; Hu CP
    Cancer Res; 1991 Apr; 51(7):1898-903. PubMed ID: 2004373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of genes for insulin and insulin-like growth factors and receptors in early postimplantation mouse embryos and embryonal carcinoma cells.
    Telford NA; Hogan A; Franz CR; Schultz GA
    Mol Reprod Dev; 1990 Oct; 27(2):81-92. PubMed ID: 1701096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.
    Nelson JB; Chan-Tack K; Hedican SP; Magnuson SR; Opgenorth TJ; Bova GS; Simons JW
    Cancer Res; 1996 Feb; 56(4):663-8. PubMed ID: 8630991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
    Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
    Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.